The impact of rapid molecular diagnostic testing for respiratory viruses on outcomes for emergency department patients

Abstract

Rapid PCR testing of ED patients for influenza virus and RSV was associated with better outcomes on a range of indicators, suggesting benefits for patients and the health care system. A formal cost-benefit analysis should be undertaken.